Tyme Tech

TYME NASDAQ
1.300
+0.050
+4.00%
After Hours: 1.300 0 0.00% 17:04 07/16 EDT
Open
1.250
Prev Close
1.250
High
1.378
Low
1.250
Volume
471.50K
Avg Vol (3M)
863.91K
52 Week High
4.642
52 Week Low
0.9200
% Turnover
0.42%
Market Cap
145.54M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Tyme Tech TYME stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Tyme Technologies, Inc. is a clinical-stage biotechnology company. The Company is focused on developing cancer therapeutics that is intended to be broadly effective across tumor types and have low toxicity profiles. The Company’s therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body’s natural immune system. The Company’s lead clinical program, SM-88, is a first-in-class combination therapy in Phase II development for prostate cancer, and it is preparing to initiate an additional Phase II clinical trial for pancreatic cancer. The Company provides a novel compound for physicians to use in a treatment regimen for patients fighting six major cancers including breast, lung, prostate, gastric, esophageal and pancreatic cancers.
MORE >

Recently

Name
Price
%Change